# RASONQUE
> **NDA220910** · New Drug Application · Sponsor: REVOLUTION MEDICINES · Approved 2026-08-26
## Drug
- **FDA Application Number:** NDA220910
- **Application type:** New Drug Application
- **Brand name:** RASONQUE
- **Generic name:** DARAXONRASIB
- **Active ingredients:** DARAXONRASIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** REVOLUTION MEDICINES
- **Manufacturer:** Revolution Medicines, Inc.
- **First approval:** 2026-08-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220910)
---
*MORVS · CC0 1.0*